Clinic Directory — coming soon. Are you an Australian peptide clinic?Apply to be listed →
Independent · Australian · Education only — not medical adviceAboutEditorial standardsHow we review
HomeEncyclopediaSS-31 (Elamipretide)

SS-31 (Elamipretide)

Mitochondrial-targeting peptide

Investigational

What it is

An investigational peptide that targets mitochondrial function.

What the evidence shows

A legitimate investigational compound in mitochondrial medicine, studied in trials; not an approved Australian medicine.

Safety & reported risks

Investigational; outside trials, consumer "SS-31" is unregulated with uncertain identity and quality.

Status in Australia

Investigational. Not approved as a medicine in Australia.

How it’s lawfully accessed

No lawful consumer supply. Legitimate access would be via an approved clinical trial.

Related peptides

MOTS-cMitochondrial-derived peptideNot ARTG-approvedEpitalonPineal tetrapeptideNot ARTG-approved

Sources & further reading

This entry is general information about SS-31 (Elamipretide), not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.

Written by The Peptides.au editorial team
Editorial review Checked against current TGA, ARTG and AHPRA public guidance
Last updated 1 June 2026

This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.